Joseph Nelesen
Director, Head of the Institutional Product Manangement & Consulting
iShares

Joseph Nelesen, Ph.D., Director, is Head of the Institutional Product Management & Consulting team for U.S. iShares. He is responsible for research and delivering product expertise to global iShares clients and partners. Dr. Nelesen's service with the firm dates back to 2008, including his years with Barclay's Global Investors (BGI), which merged with BlackRock in 2009. At BGI, he served primarily with the Product Research & Development arm of iShares. Prior to joining BGI, Dr. Nelesen worked in the Investment Banking Divisions of Citigroup and Bear, Stearns & Co. in New York and Chicago. He provided M&A and corporate finance advisory to global corporate clients across sectors including telecommunications & technology, healthcare, metals & mining and financial services.

He was previously a business strategy consultant with CSG, a specialized advisory firm serving U.S. and international providers in the telecommunications and technology sectors. Dr. Nelesen received his B.A. at University of California San Diego, his M.A. and Ph.D. at Northwestern University (focused on Telecommunication Science, Economics and Policy) where he was awarded the Northwestern Graduate Fellowship, and his M.B.A. in Finance at University of North Carolina (Kenan-Flagler Business School) where he was awarded the Friedman MBA Fellowship.












  ©  Copyright 1996-2024. Capital Link, Inc. All rights reserved.

visit:   www.capitallink.com  |  www.capitallinkshipping.com  |  www.capitallinkgreece.com  |  www.capitallinkfunds.com  |  www.irprofiles.com


Disclaimer & Terms Of Use. The information herein is not an offer to buy or sell any kind of securities nor does it constitute investment advice of any kind. Capital Link does not represent or warrant the accuracy of the information in this site. The user of the site acknowledges that he/she accesses the information at his/her own risk and cannot hold Capital Link liable for any matter in any way. Please read full disclaimer and terms of use.